NCT00692692

Brief Summary

We propose to evaluate the question of whether there is a significant difference between the traditional method of serratus flap tissue expander reconstruction and the acellular matrix method.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Jun 2007

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2007

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

June 4, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 6, 2008

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
2.9 years until next milestone

Results Posted

Study results publicly available

October 11, 2013

Completed
Last Updated

March 19, 2018

Status Verified

March 1, 2018

Enrollment Period

3.5 years

First QC Date

June 4, 2008

Results QC Date

August 3, 2013

Last Update Submit

March 13, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Patient Satisfaction With the Procedure

    one year from time of operation

  • Post Surgical Infection

    Number of participants with post surgical infection

    4 weeks

Study Arms (2)

DermaMatrix

EXPERIMENTAL

experimental group with DermaMatrix acellular dermis over tissue expanders in addition to skin/soft tissue and muscle to allow for more natural appearing breast and prevention of complications

Procedure: DermaMatrix

Standard of care

ACTIVE COMPARATOR

standard of care using skin/soft tissue and muscle coverage of tissue expander for breast reconstruction after mastectomy without acellular dermal matrix

Procedure: standard of care tissue expander breast reconstruction surgery after mastectomy

Interventions

DermaMatrixPROCEDURE

experimental group with DermaMatrix acellular dermis over tissue expanders in addition to skin/soft tissue and muscle to allow for more natural appearing breast and prevention of complications

Also known as: tissue expander breast reconstruction after mastectomy
DermaMatrix

standard of care using skin/soft tissue and muscle coverage of tissue expander for breast reconstruction after mastectomy without acellular dermal matrix

Also known as: standard of care using skin/soft tissue and muscle coverage of tissue expander for breast reconstruction after mastectomy without acellular dermal matrix
Standard of care

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All women who are candidates for breast reconstruction using tissue expanders after mastectomy

You may not qualify if:

  • Other forms of breast reconstruction after mastectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Limitations and Caveats

Unable to contact PI after he left Vanderbilt. Results were entered with available data.

Results Point of Contact

Title
Jason Wendel, MD
Organization
Vanderbilt University Medical Center

Study Officials

  • Jason Wendel, MD

    Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2008

First Posted

June 6, 2008

Study Start

June 1, 2007

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

March 19, 2018

Results First Posted

October 11, 2013

Record last verified: 2018-03

Locations